Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: ADMA Biologics Inc, 3 years.
ADMA Biologics Inc
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
ADMA Biologics Inc June 4, 202573.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | ADMA Biologics Inc | Gift | −30,000 | — | — |
| Mar 17, 2026 | ADMA Biologics Inc | Gift | +30,000 | — | — |
| Mar 13, 2026 | ADMA Biologics Inc | Option exercise | +30,000 | $3.66 | $109,800 |
| Feb 9, 2026 | ADMA Biologics Inc | Grant or award | +10,690 | — | — |
| Jun 9, 2025 | ADMA Biologics Inc | Open-market sale | −20,000 | $20.96 | $419,200 |
| May 22, 2025 | ADMA Biologics Inc | Option exercise | +1,221 | $5.96 | $7,277 |
| May 22, 2025 | ADMA Biologics Inc | Open-market sale | −1,221 | $20.12 | $24,567 |
| May 21, 2025 | ADMA Biologics Inc | Option exercise | +7,779 | $5.96 | $46,363 |
| May 21, 2025 | ADMA Biologics Inc | Open-market sale | −7,779 | $20.32 | $158,069 |
| Feb 19, 2025 | ADMA Biologics Inc | Grant or award | +10,889 | — | — |
| Sep 9, 2024 | ADMA Biologics Inc | Option exercise | +9,000 | $10.80 | $97,200 |
| Sep 9, 2024 | ADMA Biologics Inc | Open-market sale | −9,000 | $18.47 | $166,230 |
| Feb 26, 2024 | ADMA Biologics Inc | Grant or award | +24,040 | — | — |
| Mar 6, 2023 | ADMA Biologics Inc | Grant or award | +25,815 | — | — |
Questions about Lawrence P. Guiheen
What boards is Lawrence P. Guiheen on?
Lawrence P. Guiheen sits on the board of ADMA Biologics Inc.
How long has Lawrence P. Guiheen served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.